Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00423657 · ClinicalTrials.gov registry record · Phase 3
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
A Phase 3 study of Bacterial Infections, sponsored by Forest Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 680
- Enrollment target
- 20
- Study locations
NCT00423657 is a Phase 3 study of Bacterial Infections that has completed, run by Forest Laboratories. The registered enrollment target is 680 participants, above the 101-participant average among 17 other Bacterial Infections trials with a reported enrollment target (573% higher). The trial reports 20 study locations across 12 states.
The verdict
NCT00423657, a Phase 3 study of Bacterial Infections, has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 680 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin infections in adults.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG ceftaroline
- DRUG vancomycin plus aztreonam
Study Locations (20)
California
- Investigational Site - Buena Park
- Investigational Site - Hawaiian Gardens
- Investigational Site - Los Angeles
- Investigational Site - Pasadena
- Investigational Site - San Diego
- Investigational Site - San Jose
Other
- Investigational Site - Buenos Aires
- Investigational Site - Córdoba
- Investigational Site - Santa Fe
Georgia
- Investigational Site - Columbus
- Investigational Site - Marietta
Florida
- Investigational Site - Atlantis
Illinois
- Investigational Site - Springfield
Maryland
- Investigational Site - Baltimore
Minnesota
- Investigational Site - Minneapolis
Montana
- Investigational Site - Butte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 680 participants |
| Start Date | 2007-03 |
| Est. Completion | 2007-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00423657
The ClinicalTrials.gov registry entry for NCT00423657 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 680 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 101-participant average among 17 other Bacterial Infections trials with a reported enrollment target (573% higher). The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bacterial Infections appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00423657 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, Other, Georgia.
Frequently Asked Questions
What is clinical trial NCT00423657 about?
NCT00423657 is a clinical study titled "Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections". The purpose of this study is to determine whether ceftaroline is effective and safe in the treatment of complicated skin infections in adults.
What is the current status of trial NCT00423657?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 680 participants. The study started on 2007-03. Estimated completion is 2007-12.
What conditions does trial NCT00423657 study?
This clinical trial studies the following conditions: Bacterial Infections.
What interventions are being tested in trial NCT00423657?
The interventions under investigation include: Placebo (DRUG), ceftaroline (DRUG), vancomycin plus aztreonam (DRUG).
Who is sponsoring clinical trial NCT00423657?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00423657 being conducted?
This trial has 20 study locations across California, Florida, Georgia, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
RECRUITING · Phase 3
-
Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
COMPLETED · Phase 3
-
[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
RECRUITING · Phase 1
-
A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment
RECRUITING · Phase 1
-
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
ACTIVE NOT RECRUITING · Phase 1
-
Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.